Trade

with

Alkermes PLC
(NASDAQ: ALKS)
AdChoices
45.91
+0.63
+1.39%
After Hours :
45.91
0.00
0.00%

Open

45.30

Previous Close

45.28

Volume (Avg)

760.92k (864.13k)

Day's Range

45.27-46.39

52Wk Range

34.28-54.25

Market Cap.

6.60B

Dividend Rate ( Yield )

-

Beta

1.19

Shares Outstanding

145.83M

P/E Ratio (EPS)

333.33 (0.14)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 575.55M

    • Net Income

    • 24.98M

    • Market Cap.

    • 6.60B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • 2.38

    • Beta

    • 1.19

    • Forward P/E

    • 92.59

    • Price/Sales

    • 11.59

    • Price/Book Value

    • 4.95

    • Price/Cash flow

    • 47.17

      • EBITDA

      • 158.19M

      • Return on Capital %

      • -

      • Return on Equity %

      • -

      • Return on Assets %

      • -

      • Book Value/Share

      • 9.27

      • Shares Outstanding

      • 145.83M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 45.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.63

        • Cashflow Estimate

        • 1.18

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.70

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -49.10

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 19.05

          • 63.43

          • Net Income

            5-Year Annual Average

          • -31.60

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 73.70

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -6.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -6.30

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.26

              • 0.76

              • Current Ratio

              • 8.68

              • 2.92

              • Quick Ratio

              • 7.61

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.37

              • 2.21

              • Book Value/Share

              • 9.27

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 322.58

                • 217.39

                • P/E Ratio 5-Year High

                • 394.68

                • 634.30

                • P/E Ratio 5-Year Low

                • 54.85

                • 124.82

                • Price/Sales Ratio

                • 11.05

                • 9.52

                • Price/Book Value

                • 4.73

                • 8.61

                • Price/Cash Flow Ratio

                • 47.17

                • 50.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -

                    (-0.20)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -

                    (-1.10)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -

                    (1.80)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • -

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  81.81M
                  Operating Margin
                  14.21
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  47.17
                  Ownership

                  Institutional Ownership

                  99.76%

                  Top 10 Institutions

                  63.11%

                  Mutual Fund Ownership

                  74.73%

                  Float

                  60.37%

                  5% / Insider Ownership

                  1.03%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Growth Company Fund

                  •  

                    10,838,660

                  • 7.60

                  • 7.43

                  • Vanguard Health Care Fund

                  •  

                    6,135,913

                  • 18.45

                  • 4.21

                  • T. Rowe Price Mid Cap Growth Fund

                  •  

                    5,250,000

                  • 0.00

                  • 3.60

                  • CREF Stock

                  •  

                    3,352,431

                  • -3.02

                  • 2.30

                  • T. Rowe Price Health Sciences Fund

                  •  

                    3,186,900

                  • -3.38

                  • 2.19

                  • Federated Kaufmann Fund

                  •  

                    2,880,000

                  • -1.54

                  • 1.98

                  • Invesco American Franchise

                  •  

                    2,728,884

                  • 22.85

                  • 1.90

                  • Fidelity® Series Growth Company Fund

                  •  

                    2,599,792

                  • 7.94

                  • 1.78

                  • Vanguard Small Cap Index

                  •  

                    2,532,997

                  • 0.54

                  • 1.74

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    20,225,934

                  • +0.59%

                  • 13.89

                  • Fidelity Management and Research Company

                  •  

                    20,223,225

                  • -0.68%

                  • 13.88

                  • T. Rowe Price Associates, Inc.

                  •  

                    16,128,089

                  • -1.37%

                  • 11.07

                  • Vanguard Group, Inc.

                  •  

                    8,581,736

                  • +0.21%

                  • 5.89

                  • Invesco Asset Management Ltd.

                  •  

                    6,955,667

                  • +17.14%

                  • 4.78

                  • TIAA-CREF Investment Management LLC

                  •  

                    4,974,306

                  • +67.90%

                  • 3.41

                  • Invesco Advisers, Inc

                  •  

                    4,041,794

                  • +21.65%

                  • 2.77

                  • BlackRock Fund Advisors

                  •  

                    3,728,321

                  • +2.30%

                  • 2.56

                  • Frontier Capital Management CO Inc

                  •  

                    3,602,431

                  • -0.98%

                  • 2.47

                  • Federated Global Inv Mgmt Corp

                  •  

                    3,481,823

                  • +845.89%

                  • 2.39

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Slow Growth

                  Style

                  Mid Growth

                  Alkermes PLC is a biotechnology company. It is engaged in developing, manufacturing and commercializing medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious diseases. It has a diversified portfolio of more than 20 commercial drug products and a clinical pipeline of product candidates that address central nervous system disorders such as addiction, schizophrenia and depression. The Company relies on its manufacturing facility in Wilmington, Ohio for the manufacture of RISPERDAL CONSTA, VIVITROL, polymer for BYDUREON and some of its product candidates.

                  Key People

                  Richard F. Pops

                  Chairman of the Board/Director/CEO

                  James M. Frates

                  CFO/Chief Accounting Officer/Senior VP

                  Paul J. Mitchell

                  Director

                  David W. Anstice

                  Director

                  Geraldine A. Henwood

                  Director

                  • Alkermes PLC

                  • Connaught House

                  • Dublin, 4

                  • IRL.Map

                  • Phone: +353 17728000

                  • Fax: -

                  • alkermes.com

                  Incorporated

                  2011

                  Employees

                  1,250

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: